Home/Pipeline/Platform Discovery

Platform Discovery

Multiple (Infectious Diseases, Oncology)

DiscoveryActive

Key Facts

Indication
Multiple (Infectious Diseases, Oncology)
Phase
Discovery
Status
Active
Company

About Generare

Generare is pioneering a new paradigm in drug discovery by systematically accessing the estimated 97% of microbial chemistry that has never been expressed or screened. The company's integrated platform combines microbiology, analytics, and data science to extract, purify, identify, and annotate novel natural molecules at industrial scale, creating a unique and proprietary dataset. Each discovered molecule enriches its predictive algorithms, creating a compounding data advantage aimed at delivering high-quality drug candidates, particularly in areas of high unmet need like antimicrobial resistance. Based in Paris, Generare is a private, pre-revenue platform company building a foundational asset in bioactive natural product discovery.

View full company profile